EOG
39
3
PEP
53
2
TROW
24
-8
NTRS
52
7
RF
48
4
GRMN
48
2
ZION
55
7
KLAC
63
6
MAR
33
3
L
62
3
PNC
55
3
UAL
51
6
PAYX
44
2
CCL
53
6
HES
67
4
PLD
48
5
GT
39
2
IP
54
4
NFLX
65
3
AIZ
82
9
EOG
39
3
PEP
53
2
TROW
24
-8
NTRS
52
7
RF
48
4
GRMN
48
2
ZION
55
7
KLAC
63
6
MAR
33
3
L
62
3
PNC
55
3
UAL
51
6
PAYX
44
2
CCL
53
6
HES
67
4
PLD
48
5
GT
39
2
IP
54
4
NFLX
65
3
AIZ
82
9
Financhill
Back

Bicara Therapeutics Vs. Fabrinet Industry Stock Comparison

Sell
46

BCAX
Bicara Therapeutics

Last Price:
$12.45
Seasonality Move:
--
Buy
56

FN
Fabrinet

Last Price:
$220.16
Seasonality Move:
2.27%
Sell
46
Bicara Therapeutics (BCAX) is a Sell

Is Bicara Therapeutics a Buy, Sell or Hold?

  • The current Bicara Therapeutics [BCAX] share price is $12.42. The Score for BCAX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • BCAX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
56
Fabrinet (FN) is a Buy

Is Fabrinet a Buy, Sell or Hold?

  • The current Fabrinet [FN] share price is $220.00. The Score for FN is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • FN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BCAX Stock Price Chart

What is Bicara Therapeutics's stock price today?

  • The Bicara Therapeutics share price today is $12.42
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCAX is experiencing selling pressure, which indicates risk of future bearish movement.

FN Stock Price Chart

What is Fabrinet's stock price today?

  • The Fabrinet share price today is $220.00
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FN is experiencing slight buying pressure.

BCAX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.07 Buy
Relative Strength Index (14 RSI): 42.78 Sell
Chaikin Money Flow: -444852 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.31 - 14.39) Sell
Bollinger Bands (100): (13 - 21.26) Sell

FN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.77 Sell
Relative Strength Index (14 RSI): 54.68 Buy
Chaikin Money Flow: 117700 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (195.63 - 225.15) Buy
Bollinger Bands (100): (211.17 - 249.15) Sell

BCAX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.27 Sell
20-day SMA: 13.51 Sell
50-day SMA: 13.53 Sell
200-day SMA: 0 Buy
8-day EMA: 13.65 Sell
20-day EMA: 13.58 Sell
50-day EMA: 14.06 Sell
200-day EMA: 11.13 Buy

FN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 201.13 Buy
20-day SMA: 209.75 Buy
50-day SMA: 219.4 Buy
200-day SMA: 232.87 Sell
8-day EMA: 207.4 Buy
20-day EMA: 208.55 Buy
50-day EMA: 216.92 Buy
200-day EMA: 221.86 Sell

Bicara Therapeutics Earnings Growth & BCAX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.18 per share, and a decrease next year of $0.54 per share.

Fabrinet Earnings Growth & FN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.40 per share, an increase next quarter of $0.02 per share, an increase this year of $1.55 per share, and an increase next year of $1.33 per share.

Bicara Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Fabrinet Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):